Katherine T. Murray, MD

Katherine T. Murray, MD, is Professor of Medicine and Pharmacology in the Department of Medicine at Vanderbilt University Medical Center. She completed an Internal Medicine residency at Vanderbilt, a fellowship in Clinical Pharmacology also at Vanderbilt, and a fellowship in Cardiovascular Medicine and Clinical Cardiac Electrophysiology at Duke University.

Dr. Murray’s major scientific interest is to improve the treatment of cardiac arrhythmias and to identify novel therapeutic targets. Recent work has focused on the role of reactive lipid mediators on oxidative stress injury on susceptibility to atrial fibrillation in mouse models. This work was instrumental to the funding of an American Heart Association Strategically Focused Research Network grant on atrial fibrillation at Vanderbilt.

Dr. Murray also collaborates with investigators in the Department of Health Policy on pharmacoepidemiologic studies to investigate the risk of sudden cardiac death for noncardiac medications, as well as outcome risks of oral anticoagulant medications. She has been a writing committee member for the American College of Cardiology/ American Heart Association/Heart Rhythm Society Guidelines for the Management of Patients With Atrial Fibrillation since 2014, including the 2019 Update, and she is a member of the EHRA/HRS/APHRS/SOLAECE expert consensus panel on atrial cardiomyopathies. Dr. Murray is a fellow of the American Heart Association and the Heart Rhythm Society, serving as a Judge/Committee Chairman for the HRS Young Investigators Competition. She has been an invited speaker locally and nationally at academic institutions and scientific meetings, and she has served on numerous clinical trial event committees.

Dr. Murray has authored 98 original investigations with more than 130 total publications. She attends clinically on inpatient arrhythmia consult service and in the Heart Station at Vanderbilt University Hospital and runs an outpatient clinic for patients with cardiac arrhythmias.